Mumbai-based Wockhardt mentioned on Monday it has entered right into a fill-and-finish settlement with the UK authorities to produce COVID-19 vaccines. Fill-and-finish is the ultimate manufacturing step of placing vaccines into vials or syringes and packaging them. In a regulatory submitting throughout market hours, Wockhardt mentioned it can manufacture the product at its Wrexham, North Wales-based subsidiary, CP Pharmaceuticals. Shares in Wockhardt surged to settle at Rs 303.40 apiece on the BSE, caught within the higher circuit at 10 per cent, after the announcement. (Track Wockhardt Shares Here)
As a part of the deal, Wockhardt mentioned it has reserved the manufacturing capability “to allow for the supply of multiple vaccines to the UK Government in its fight against COVID19, including AZD1222, the vaccine co-invented by the University of Oxford and its spinout company, Vaccitech and licensed by AstraZeneca”.
“The pandemic of COVID-19 is a challenge for all and needs a concerted effort to overcome. We are proud to be collaborating with the UK Government to make vaccines available and the arrangement brings in a huge sense of purpose and pride, it upholds our ongoing commitment to fight against such a pandemic of global human importance,” said Dr Habil Khorakiwala, founder chairman of Wockhardt.
“As a global organisation, we are focused and committed to assist in mitigating the worldwide impact of COVID-19,” he added.
Wockhardt mentioned the UK authorities has reserved one fill-and-finish manufacturing line for its unique use over the subsequent 18 months to ensure the availability of vaccines required to struggle COVID-19.
“Ensuring the UK has the potential to analysis, develop and manufacture a secure and efficient vaccine is important in our struggle in opposition to coronavirus… Today we have now secured extra capability to fabricate tens of millions of doses of a number of Covid-19 candidates, guaranteeing the availability of vaccines we have to shield individuals throughout the UK quickly and in giant numbers,” mentioned Alok Sharma, the UK authorities’s secretary of state for enterprise, power and industrial technique.
The Wockhardt inventory sharply outperformed the benchmark S&P BSE Sensex benchmark index which prolonged losses to a fourth straight day amid a selloff in banking shares.
Wockhardt has been one of many largest suppliers for the UK’s National Health Service (NHS) for greater than 20 years.